6505--Radiopharmaceutical: Axumin Amyvid Radioisotope

The Orlando Veterans Affairs Healthcare System intends to solicit and award a requirement contract for Radiopharmaceuticals: Amyvid and Axumin. The period of performance will start 02/01/2021. The Primary North American Industry Classification System (NAICS) for this acquisition is 325412, with a related small business size standard of 1,250 employees.

The proposed action is for Firm-Fixed Price (FFP) Indefinite Delivery Indefinite Quantity contract, which will be advertised as Unrestricted-other than Small Business. The solicitation will be posted on or about 21 December 2020, via beta.sam.gov website. The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-02 11/23/2020. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. For further information, please contact Jessica Kiser, Contract Specialist at Jessica.Kiser@va.gov.

ALL RESPONSES ARE DUE VIA EMAIL TO JESSICA.KISER@VA.GOV BY JANUARY 18, 2021, 12:00 PM, EASTERN STANDARD TIME (EST).

ALL QUESTIONS IN REFERENCE TO THIS SOLICITATION ARE DUE NO LATER THAN 12:00 PM EST, ON JANUARY 7, 2021 VIA EMAIL TO: JESSICA.KISER@VA.GOV

RESPONSES TO YOUR QUESTIONS WILL BE PROVIDED NLT JANUARY 8, 2021 12:00 PM STANDARD TIME (EST).